ProShare Advisors’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,245
Closed -$78K 1711
2020
Q2
$78K Buy
+10,245
New +$78K ﹤0.01% 1598
2020
Q1
Sell
-12,830
Closed -$156K 1742
2019
Q4
$156K Sell
12,830
-1,038
-7% -$12.6K ﹤0.01% 1640
2019
Q3
$160K Sell
13,868
-582
-4% -$6.72K ﹤0.01% 1482
2019
Q2
$144K Sell
14,450
-2,036
-12% -$20.3K ﹤0.01% 1496
2019
Q1
$212K Buy
16,486
+196
+1% +$2.52K ﹤0.01% 1442
2018
Q4
$247K Sell
16,290
-2,840
-15% -$43.1K ﹤0.01% 1260
2018
Q3
$383K Sell
19,130
-926
-5% -$18.5K ﹤0.01% 1233
2018
Q2
$391K Sell
20,056
-1,840
-8% -$35.9K ﹤0.01% 1234
2018
Q1
$441K Sell
21,896
-3,443
-14% -$69.3K ﹤0.01% 1151
2017
Q4
$336K Buy
25,339
+2,365
+10% +$31.4K ﹤0.01% 1319
2017
Q3
$424K Buy
22,974
+1,364
+6% +$25.2K ﹤0.01% 1027
2017
Q2
$398K Sell
21,610
-1,531
-7% -$28.2K ﹤0.01% 1037
2017
Q1
$522K Sell
23,141
-5,821
-20% -$131K 0.01% 989
2016
Q4
$1.01M Buy
28,962
+3,279
+13% +$114K 0.01% 774
2016
Q3
$629K Sell
25,683
-5,096
-17% -$125K 0.01% 854
2016
Q2
$736K Buy
30,779
+37
+0.1% +$885 0.01% 816
2016
Q1
$719K Sell
30,742
-2,191
-7% -$51.2K 0.01% 843
2015
Q4
$994K Buy
32,933
+3,651
+12% +$110K 0.01% 739
2015
Q3
$1.16M Buy
29,282
+1,033
+4% +$41K 0.02% 627
2015
Q2
$1.95M Buy
28,249
+98
+0.3% +$6.77K 0.03% 527
2015
Q1
$1.54M Buy
28,151
+7,117
+34% +$389K 0.02% 648
2014
Q4
$896K Buy
21,034
+1,043
+5% +$44.4K 0.01% 914
2014
Q3
$638K Sell
19,991
-3,952
-17% -$126K 0.01% 1262
2014
Q2
$496K Sell
23,943
-14,593
-38% -$302K 0.01% 1594
2014
Q1
$746K Buy
38,536
+27,389
+246% +$530K 0.01% 1542
2013
Q4
$271K Sell
11,147
-10,099
-48% -$246K ﹤0.01% 1192
2013
Q3
$456K Buy
21,246
+3,256
+18% +$69.9K 0.01% 1548
2013
Q2
$400K Buy
+17,990
New +$400K 0.01% 1490